Related Experiment Video
Updated: May 22, 2026
Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
Enhanced T cell immunity by B7-H4 downregulation in nonsmall-cell lung cancer cell lines
1Department of Respiratory Medicine, Zhongda Hospital, Southeast University, Nanjing, China.
Objectives:
T cell immunity plays a critical role in host immune surveillance of tumour cell growth and metastatic spread. This study used small hairpin (sh)RNA-mediated gene silencing to target VTCN1 (B7-H4) expression in a nonsmall-cell lung cancer (NSCLC) cell line (A549) and evaluated the effects on T cell immune activity using an in vitro coculture system.
Methods:
VTCN1-specific shRNA-expressing plasmid was transfected into A549 cells. Mock transfected and empty plasmid-transfected A549 cells served as controls. VTCN1 expression in A549 cells was determined by reverse transcription-polymerase chain reaction (RT-PCR) for VTCN1 mRNA and Western blotting for B7-H4 protein. Transfected A549 cells were cocultured with Jurkat cells. Jurkat cells were examined for proliferation, apoptosis, cell cycle distribution and intracellular cytokine mRNA and protein levels.
Results:
VTCN1-specific shRNA efficiently knocked down VTCN1 mRNA and B7-H4 protein levels in A549 cells. This downregulation led to enhanced Jurkat cell proliferation, decreased apoptosis, stimulated cell cycle progression and elevated production of interferon-γ, interleukin (IL)-10 and IL-2.
Conclusions:
B7-H4 negatively regulates T cell-mediated antitumour immunity in NSCLC.
Insights
Targeting VTCN1 (B7-H4) in non-small-cell lung cancer (NSCLC) with shRNA enhances T cell immunity. This approach boosts T cell proliferation and cytokine production, crucial for anti-tumour responses.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- T cell immunity is vital for detecting and eliminating cancer cells.
- VTCN1 (B7-H4) is implicated in immune evasion by tumors.
- Non-small-cell lung cancer (NSCLC) poses a significant therapeutic challenge.
Purpose of the Study:
- To investigate the role of VTCN1 (B7-H4) in NSCLC immune surveillance.
- To evaluate the impact of VTCN1 gene silencing on T cell activity in NSCLC.
Main Methods:
- Utilized small hairpin (sh)RNA to silence VTCN1 expression in A549 NSCLC cells.
- Confirmed VTCN1 knockdown via RT-PCR and Western blotting.
- Assessed T cell (Jurkat) responses in vitro co-culture assays.
Main Results:
- Efficiently reduced VTCN1 mRNA and B7-H4 protein in NSCLC cells.
- Demonstrated increased T cell proliferation and cell cycle progression.
- Observed decreased T cell apoptosis and elevated cytokine production (IFN-γ, IL-10, IL-2).
Conclusions:
- VTCN1 (B7-H4) acts as a negative regulator of T cell-mediated anti-tumour immunity in NSCLC.
- Downregulating VTCN1 enhances T cell effector functions against NSCLC.
- Targeting VTCN1 may represent a viable strategy to augment anti-tumour immunity.
Related Concept Videos
01:27Tumor Immunotherapy
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...